A novel murine infection model for Shiga toxin–producing Escherichia coli

The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin–associated hemolytic uremic syndrome in humans and mice

(2012) Tania N. Petruzziello-Pellegrini et al.   JOURNAL OF CLINICAL INVESTIGATION

Allele- and Tir-Independent Functions of Intimin in Diverse Animal Infection Models

(2012) Emily M. Mallick et al.   Frontiers in Microbiology

Chemokine Receptor CCR1 Disruption Limits Renal Damage in a Murine Model of Hemolytic Uremic Syndrome

(2011) Maria V. Ramos et al.   AMERICAN JOURNAL OF PATHOLOGY

Biomarkers of kidney injury

(2011) Anja Urbschat et al.   BIOMARKERS

Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome

(2011) A.-l. Stahl et al.   BLOOD

Acute kidney injury biomarkers: renal angina and the need for a renal troponin I

(2011) Stuart L Goldstein   BMC Medicine

Mouse Models ofEscherichia coliO157:H7 Infection and Shiga Toxin Injection

(2011) Krystle L. Mohawk et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis

(2011) M. Morigi et al.   JOURNAL OF IMMUNOLOGY

Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study

(2011) Martina Bielaszewska et al.   LANCET INFECTIOUS DISEASES

Shiga Toxin Interaction with Human Intestinal Epithelium

(2011) Stephanie Schüller   Toxins

Escherichia coli O157

(2010) Hugh Pennington   LANCET

Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora

(2010) Krystle L. Mohawk et al.   MICROBIAL PATHOGENESIS

Complement in Typical Hemolytic Uremic Syndrome

(2010) Dorothea Orth et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7

(2010) Krystle L. Mohawk et al.   VACCINE

Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease

(2010) Tom G. Obrig   Toxins

Utility of the Citrobacter rodentium infection model in laboratory mice

(2009) Diana Borenshtein et al.   CURRENT OPINION IN GASTROENTEROLOGY

Clinical practice

(2009) Johanna Scheiring et al.   EUROPEAN JOURNAL OF PEDIATRICS

Shiga Toxin 2 Targets the Murine Renal Collecting Duct Epithelium

(2009) M. A. Psotka et al.   INFECTION AND IMMUNITY

Decreased Expression of Colonic Slc26a3 and Carbonic Anhydrase IV as a Cause of Fatal Infectious Diarrhea in Mice

(2009) D. Borenshtein et al.   INFECTION AND IMMUNITY

Verocytotoxin-producing Escherichia coli (VTEC)

(2009) Mohamed A. Karmali et al.   VETERINARY MICROBIOLOGY

Modulation of Acute Diarrheal Illness by Persistent Bacterial Infection

(2008) M. E. McBee et al.   INFECTION AND IMMUNITY

Pathogenesis of Renal Disease Due to Enterohemorrhagic Escherichia coli in Germ-Free Mice

(2008) K. A. Eaton et al.   INFECTION AND IMMUNITY

Mouse Model of Hemolytic-Uremic Syndrome Caused by Endotoxin-Free Shiga Toxin 2 (Stx2) and Protection from Lethal Outcome by Anti-Stx2 Antibody

(2008) K. A. D. Sauter et al.   INFECTION AND IMMUNITY

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)

(2008) Johanna Scheiring et al.   PEDIATRIC NEPHROLOGY